FCVB 2022

Dear Partner,

The Frontiers in Cardiovascular Biomedecine congresses are increasingly considered as one of the most relevant exchange platforms for basic and translational cardiovascular biology.

This year's congress marks an exciting return to in-person exchange for our audience and is expected to attract upwards of 600 attendees.

For further consultation on, and management of your corporate investment and strategy, please contact us at industry@escardio.org
For any logistical queries, please contact us at fcvbservices@escardio.org

ESC Industry Team

 Industry Opportunities

 Sales terms and conditions

 ESC Guidelines for Industries @ Congresses

 ESC Guidelines for Industries @ FCVB 2022

On October 1, 2020, new applications of French Anti-Gift regime entered into effect.
The new framework governs transfers of value to healthcare professional organisations by pharmaceutical, medical device, diagnostic and other healthcare companies.

As an healthcare organisation based in France, this regime applies to the interaction between the ESC and our healthcare industry partners. The ESC is working in full respect of this regime and provide you with the following documents to facilitate your procedures with the French authorities :

• Information note for application

• Industry Opportunities [programme] (in French)

07 Feb	Application deadline
14 Feb	Late-breaking science submission deadline
28 Feb	Early onsite registration fee deadline
	French authorities submission deadline
14 Mar	Industry Sessions - Submission deadline for scientific programme
29 Apr-01 May	FCVB 2022